VVTM VVT Med Inc.
VVT Med Inc. develops, manufactures, and commercializes minimally invasive, non-thermal, and nontumescent solutions for the treatment of varicose veins. It offers V-BLOCK, a treatment kit for vein diameters; and ScleroSafe for combining negative pressure and mechano-chemical ablation in one smart systems. The company was incorporated in 2007 and is based in Kfar Saba, Israel.…
Industry Peers
Medical DevicesKey Statistics
About VVT Med (CVE: VVTM)
›
VVT Med (CVE: VVTM) is listed on the TSX Venture Exchange, where its shares trade in CAD. It belongs to the Medical Devices industry, part of the Healthcare sector, and reports about 8 employees.
The shares were at 0.1700 CAD on 19 November 2026, down 39.3% over 52 weeks. Its 52-week range is 0.1400 CAD to 0.4500 CAD: the price is 62.2% below the high and 21.4% above the low.
Its market capitalisation is 12.34M CAD.
VVT Med reports return on equity of 218.5% and revenue up 135.7% year over year.
Its debt exceeds its cash by 1.16M USD. Its Piotroski F-score is 4 out of 9, an average reading of its financial health. The next earnings report is expected on 1 December 2026.